Shenzhen YHLO Biotech Co., Ltd. (YHLO) is a leading company of immunoassay solutions in China. Founded in 2002 and headquartered in Shenzhen China, YHLO is specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
YHLO has strategic cooperation with famous universities, research institutes and high-tech enterprises from USA, Germany, Italy, etc., dedicated to meeting global clinical demands and developing instruments and reagents with our own intellectual properties.
YHLO has achieved a lot of innovations:
World's first CLIA assays for Inhibin B, Adiponectin, ZnT8A, RA33, etc.
China's first monotest ELISA analyzer - UNION
China's first ESR analyzer with direct EDTA tube testing – VISION
China's first high-speed chemiluminescence system - iFlash 3000 (300 T/H)
Chinas first autoimmune assays in CLIA, LIA and ELISA platforms
Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc. Most YHLO products in the market are CFDA certified and CE marked, and we have entered more than 60 countries across Europe, Australia, Latin America, Africa and Asia.
Our mission is to focus on healthcare and become a reliable and respected IVD enterprise globally.